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The P23T mutant of human D-crystallin (HGD) is associated with
cataract. We have previously investigated the solution properties
of thismutant, aswell as those of the closely related P23V and P23S
mutants, and shown that although mutations at site 23 of HGD do
not produce a significant structural change in the protein, they
nevertheless profoundly alter the solubility of the protein. Remark-
ably, the solubility of the mutants decreases with increasing
temperature, in sharp contrast to the behavior of the native
protein. This inverted solubility corresponds to a strong increase in
the binding energy with temperature. Here we have investigated
the liquid–liquid coexistence curve and the diffusivity of the P23V
mutant and find that these solution properties are unaffected by
the mutation. This means that the chemical potentials in the
solution phase are essentially unaltered. The apparent discrepancy
between the interaction energies in the solution phase, as com-
pared with the solid phase, is explicable in terms of highly aniso-
tropic interprotein interactions, which are averaged out in the
solution phase but are fully engaged in the solid phase.
cataract  lens  protein phase diagram  quasielastic light scattering
Human D-crystallin (HGD) is an important member of the-crystallin family of proteins found in the human lens.
Mutations in HGD in particular have been associated with a
number of childhood cataracts (1–4). Recently, the P23T mutant
of HGD has been associated with coralliform, cerulean, and
fasciculiform cataract phenotypes (refs. 1 and 2 and references
therein). Mutation at site 23 of HGD is only one of a number of
single point mutations, including the R14C, R58H, and R36S
mutations, that occur on the CRGD gene and that have been
linked with early-onset cataract disease (5–9). Physicochemical
characterization of the mutant proteins shows why these changes
result in the formation of either covalently linked aggregates in
the case of R14C (5, 6) or crystals in the case of the R58H and
R36S mutants (7–9). The P23T mutation results in decreased
solubility of the protein, leading to protein aggregation and light
scattering, and hence to lens opacity. However, the aggregates
are not covalently linked, since the aggregation process is
completely reversible with temperature.
Formation of protein aggregates is a common motif in many
‘‘condensation diseases,’’ which include cataract (10), sickle-cell
anemia (11, 12), andAlzheimer’s disease (13, 14), as well as other
amyloid diseases such as diabetes and Parkinson’s disease (15,
16). These examples highlight the importance of understanding
the processes that lead to the formation of condensed protein
phases under physiological conditions. In particular, protein
condensation diseases resulting from a single amino acid sub-
stitution provide favorable conditions for biophysical analysis
because such substitutions produce a change in the interaction
potential between the proteins but may not necessarily result in
significant structural changes to the protein itself. The first
example of a protein condensation disease being associated with
a single amino acid substitution was sickle cell anemia (11).
Interestingly, hemoglobin S (HbS) displays retrograde solubility
in its phase diagram and also a lower consolute temperature (17).
A more detailed investigation of P23T and other mutants of
HGD at site 23 (i.e., P23S and P23V) has shown that unusual
phase behavior is displayed by all three of these mutants,
implying that the region around site 23 of HGD is important in
maintaining the solubility of the protein (1). Although substi-
tuting a single amino acid residue at site 23 does not alter the
regular form of the coexistence curve, it results in decreased
protein solubility and remarkably inverts the form of the solu-
bility line. The mutation responsible for the inversion of the
solubility line in vivo is P23T. Unfortunately, P23T has very low
solubility [5 mg/ml;  0.0035. The volume fraction  csp,
where c is the concentration in milligrams per milliliter and sp
is the partial specific volume 7.1  104 ml/mg (18) over the
temperature range investigated]. With such low solubility, many
features of the phase diagram are not accessible and cannot be
measured, including liquid–liquid phase separation (LLPS). We
chose to focus on the more soluble P23V substitution because
this mutant demonstrates the same inverse solubility as P23T but
over a larger concentration range, allowing us to investigate
LLPS, aggregation, and crystallization. Although we will focus
our experimental efforts on the P23V mutant, it will be possible
to comment on the behavior of all three mutants.
We first summarize the state of our knowledge regarding the
P23V mutant of HGD. The solubility line of mutants of HGD at
site 23 shows a retrograde temperature dependence. The re-
placement of Thr-23 with a Ser or Val residue shifts the location
of the inverted solubility line to higher concentrations (1). On
the other hand, LLPS for P23V appears to be the same as for
HGD, and the CD, Raman, and IR spectra show that no major
secondary or tertiary structural changes take place upon mu-
tagenesis (1).
Given the unusual nature of the phase diagram, we undertook
further studies of these phase separation phenomena. We have
extended the data for the LLPS, confirming that it is in fact the
same as for the native protein. Furthermore, we have used
quasielastic light scattering (QLS) spectroscopy to probe the
interactions between the proteins in the soluble region of the
phase diagram. We have also produced crystals of P23V and will
comment on this in relation to the phase diagram.
Results and Discussion
Phase Diagram. The P23V phase diagram is shown in Fig. 1. Here
we redraw the solubility data from ref. 1 and include our
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measured coexistence curve for the protein. Only a portion of
the LLPS phase boundary is shown. On the phase diagram, there
is a narrow gap between the coexistence curve and the apparent
solubility line in region A where the protein can be brought to
higher  without aggregation. The maximum protein concen-
tration we could reach at a temperature of 277 K (4°C) was100
mg/ml (  0.071) before aggregation began to occur. Conse-
quently, this was the highest concentration at which measure-
ments of LLPS could be taken. The LLPS for the native protein
is also shown for comparison. Clearly, the coexistence curves for
both native and mutant proteins are the same.
In region B of the phase diagram, the protein condenses to
form a solid phase that coexists with the protein monomer. The
nature of the condensed, solid phase depends on the preparation
conditions of the protein solution. In the vast majority of region
B, the solid phase exists as protein aggregates. In a very narrow
part of region B, we have been able to suppress aggregation long
enough to allow crystallization to occur. The line that divides
regions A and B of the phase diagram, which we call the
‘‘solubility line,’’ describes the coexistence of protein aggregates
with protein monomer. This protein aggregation is completely
reversible with temperature and, on the time scale of our
experiments, appears to be at equilibrium. Therefore, for this
work we assume that the solubility line is an equilibrium phase
boundary.
We produced crystals of P23V within a narrow section of
region B on the phase diagram, when solutions were passed
through 0.02-m filters (Fig. 1). Samples at concentrations
between 20 and 40 mg/ml (  0.014 to 0.028) were incubated
at 32°C (305 K) overnight. Visual examination of the glass tubes
revealed that small crystals had formed on the walls; their
crystalline order was confirmed by observation of optical bire-
fringence (Fig. 2). These crystals were of very low quality and
only grew in small numbers. Many were irregularly shaped.
Attempts to improve the number and quality of the crystals
failed because aggregation often occurred when we tried to
manipulate the samples. This further highlighted the competi-
tion between crystallization and aggregation. Protein crystals
produced from a solution at a concentration of 20 mg/ml ( 
0.014) began to melt at room temperature (20°C, 293 K), as can
be seen at the edges of the protein crystal in Fig. 2. To establish
a point on the liquidus line, crystals are usually placed in a small
volume of protein-free solvent. The protein crystals will dissolve
until equilibrium has been reached. Because of the small number
of crystals that grew, we determined the solubility of the protein
crystal by starting from a supersaturated solution (19, 20). In
solutions in which crystals grew, we lowered the temperature
until melting began to occur at the edges of the crystals. We took
this as the solubility. When this method is used, the surface may
be poisoned by impurities or imperfections arising from improp-
erly oriented proteins, thereby stopping further crystal growth
(21, 22); however, previous work (20) has shown that in practice
there is no significant difference in the results obtained using
either method.
The point at which crystal melting occurs upon lowering of the
temperature is shown on Fig. 1 (green star). This point lies very
close to the solubility line (defined by blue spheres in Fig. 1).
Because crystals form very close to this solubility line, we can
assume that aggregation occurs at low supersaturation and,
therefore, that the solubility line lies very close to the liquidus
line that describes equilibrium between protein crystals and
protein monomer.
Because aggregation occurs at low supersaturations, we found
only a narrow window in the phase diagram in which aggregation
could be suppressed in favor of crystallization. Essentially, we
suppressed aggregation long enough to allow crystallization to
occur. Given that the crystals grew only on the walls and the surface
of the protein solutions, this crystal growth was by heterogeneous
nucleation. Thus, knowledge of the phase diagram of this protein
gave us a good indication of the conditions under which crystalli-
zation might occur (i.e., at higher temperatures).
QLS. We also carried out QLS measurements that showed that in
the soluble region of the phase diagram, the diffusion coefficient
of P23V is consistent with monomeric protein, and no aggrega-
tion is observed (region A in Fig. 1).
QLS and Protein Aggregation. In region B of the phase diagram
(Fig. 1), where aggregation occurs, this aggregation was in the
form of isolated particles/aggregates of protein, with larger
hydrodynamic radii passing through the scattering volume.
These large particles always represented a very small portion of
Fig. 1. Phase diagram for P23V, showing the coexistence curve for HGD
(black spheres), the partial coexistence curve for P23V (red spheres), and the
solubility line for P23V (blue spheres). The green star is a single point of the
liquidus line, representing crystal–monomer equilibrium. The solubility line is
replotted from numerical values given in ref. 1. In region A, the protein exists
as a homogenous monomer. In region B, the protein is aggregated and is
coexisting with the protein monomer (see lower part of Fig. 2). In region C,
LLPS has occurred. The protein exists in two coexisting liquid phases, one
concentrated and one dilute. Both liquid phases contain monomeric protein.
Fig. 2. Polarization microscopy image of P23V crystals. The uneven edges in
the lower part of the image are due to melting. Crystals were grown at 32°C
and then imaged at room temperature.
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the entire sample, comprising usually5% of the total scattering
intensity (in the concentration and temperature regimes we
examined). Most of the protein remained as monomer. It is
important to note that there was no evidence of percolation or
gelation in the light scattering data. In Fig. 3 we show QLS data
for P23V at 5 mg/ml (  0.0035) at 42°C (315 K), just inside
region B of the phase diagram. At the beginning of the mea-
surement, only monomer is present in solution (Fig. 3 Upper).
After a lag time, protein aggregates begin to form, and higher
molecular weight aggregates are observed (Fig. 3 Lower). This
aggregation is reversible. Once the temperature is lowered
again, the aggregates dissolve, leaving only protein monomer in
solution.
QLS in Region A of the Phase Diagram. We carried out QLS
experiments in the soluble region of the phase diagram (Fig. 1,
region A) at a number of different temperatures, to examine the
‘‘averaged’’ interaction between the proteins in solution. The
results are shown in Fig. 4. We measured the collective diffusion
coefficient (Dc) for P23V solutions between 4 and 30 mg/ml (
0.0028 to 0.021) and at temperatures ranging from 20° to 35°C
(293–308 K), all in region A of the phase diagram. For this range
of concentrations, we would expect Dc to depend linearly on .
We linearly extrapolated Dc to   0 to determine the free-
particle diffusion coefficient, D0, which we found to be 1.15 
106cm2s1 (25°C, 298 K). This corresponds to a hydrodynamic
radius of 2.1 nm by the Stokes–Einstein equation: D0 
kT/6R, where D0 is the diffusion coefficient (in cm2/s),  is the
solvent viscosity, k is Boltzman’s constant, and R is the hydro-
dynamic radius. These samples were all measured in the region
of the phase diagram where aggregation and crystallization are
absent and multiple scattering is not present. Our D0 for HGD
is consistent withD0 for bovine B-crystallin (23). There is a high
degree of sequence homology between the -crystallins and,
because the molecular weights of bovine B-crystallin and P23V
differ by only350 Da, we would expect to measure very similar
diffusion coefficients. Bovine B-crystallin, like HGD, exhibits
LLPS and has ‘‘normal’’ solubility.
QLS Measurements and Protein Interactions. Fig. 4 shows Dc(,
T)/D0(T) data for P23V at different temperatures. Our data show
that Dc decreases with increasing protein concentration at all
temperatures between 20° and 35°C (293–308 K) investigated.
This behavior is expected from particles with attractive interac-
tions because concentration fluctuations dissipatemore slowly as
the particle concentration increases, resulting in a smaller mea-
sured D0. Our measurements of diffusivity for P23V show that
with increasing temperature, the collective diffusion coefficient
for the protein particles becomes smaller (at constant ). Both
the concentration and temperature dependence we find were
observed by Fine et al. (23) for bovine B-crystallin. In both
cases, the slope of Dc vs.  is negative and of approximately the
same magnitude (approximately 7.5 for bovine B-crystallin
and approximately5.0 for HGD), and the values for D0 of both
proteins at 25°C (298 K) agree within 10%. Several studies have
used QLS to probe interactions between proteins (23–33).
According to Muschol and Rosenberger (27),
Dc  D01  kS 	 kH	
  D01  kD
 , [1]
where the static structure factor S(q  0, )  1  kS and the
hydrodynamic interaction term H(q  0, )  1  kH. kS, kH,
and kD are defined in ref. 27. We can deduce kD at each
temperature from our data. These results are shown in Table 1.
We also include D0 at each temperature. Examining the data, kD
is negative at all temperatures. We can compare this result with
the value predicted for hard spheres, kD 1.45 [Batchelor (34)].
Clearly, our kD has the opposite sign. As the temperature
increases, our value for kD becomes slightly less negative, indi-
cating that the interactions between the protein particles become
slightly less attractive (i.e., they are approaching a more hard-
sphere, repulsive-type behavior). This solution behavior was not
initially expected because of the strong inverted temperature
dependence of the solubility. Both QLS data and LLPS data for
native and mutant proteins indicate that the solution behavior is
essentially the same for both proteins.
Comparison with HbS.We stated previously (1) that the retrograde
solubility profile of the P23V mutant has also been observed in
Fig. 3. Quasielastic light scattering for P23V. (Upper) P23V solution, 5mg/ml,
42°C, 5 min after the beginning of measurement. Clearly the protein is
monomeric. (Lower) P23V solution, 5 mg/ml, 42°C, 6 h after the beginning of
measurement. Note the appearance of particles with a higher hydrodynamic
radius, Rh, indicating aggregation of the protein. Even with protein aggre-
gates present, a significant proportion of monomer remains in solution.
Fig. 4. Dc(T, )/D0(T) vs. protein concentration (or volume fraction, ) for
P23V solutions at concentrations from 4 to 30 mg/ml at four temperatures.
Table 1. D0 and interaction parameter, kD, data shown as a
function of temperature, calculated from a fit Dc  D0(1  kD)
to the data in Fig. 4
Temperature, K D0, cm2/s kD
293 0.97  106 5.83
298 1.15  106 5.09
303 1.33  106 4.97
308 1.53  106 4.59
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the case of sickle cell hemoglobin, HbS (17). However, there is
a clear distinction between the two cases: the nature of the
solubility curve in HbS is neither a liquidus line nor a protein
monomer–aggregate equilibrium as in P23V. The HbS solubility
curve represents an equilibrium between protein monomers and
protein fibers that have polymerized and exist in equilibrium
with surrounding monomer. It is these polymer fibers that are
responsible for the deformation of red blood cells in sickle cell
anemia (17, 35). HbS also shows LLPS behavior, but it addi-
tionally has a lower consolute temperature. The features of the
HbS phase diagram are, therefore, distinct from the phase
behavior of P23V that we describe here.
Analysis of the Solubility Data. We can represent the data for the
liquidus line for native HGD and the solubility line of the mutant
proteins in terms of the magnitude and temperature dependence
of the relevant transfer chemical potential, trans, defined as
trans 
 P
0  W
0 	 	 CT , nC, 	 , [2]
where C is the chemical potential of a protein molecule with 
associated water molecules in the solid phase. C generally
represents the chemical potential in the crystal phase, but in this
case we use it to represent the aggregate phase (for the reasons
discussed earlier in this section). C is a negative number, larger
in magnitude than the negative quantity, P
0  W
0 , which is the
standard part of the chemical potential of the protein with 
associated water molecules. Therefore, trans is a positive
quantity. We may use the Van’t Hoff law, which states that the
volume fraction, , along the solubility line is related to the
transfer chemical potential, trans, according to (36)
ln 
 	   transkT  . [3]
If we define X  T0/T, where T0  298 K, it follows that  
exp  (trans/kT0)X. Using the solubility data for native HGD
(6) and the mutants, P23V, P23S, and P23T (1), we can deter-
mine trans for each protein. Plotting trans/kT0 vs. T/T0, we
find that the slope for the native protein is negative, whereas it
is positive for all of the mutant proteins. Also, using Eq. 3, we
observe that at volume fractions higher than 0.02, trans/kT0
does not depend linearly on T. It is important to determine the
reason for the nonlinearity. Here we employ a more accurate
form of Eq. 3, using the virial expansion:
ln  2B2 
 	   transkT0  X . [4]
B2, the second virial coefficient, is the second term in the virial
expansion. B2 is defined by Lomakin et al. (37):
B2 
4e 	 1	3 	 1	 	 1
 , [5a]
where   eff/kT, and from the LLPS,   1.25 and eff/kTc 
1.27 (38). B2 then becomes
B2 
4 0.953 e1.27TcT 	 1 	 1 . [5b]
We note that B2 has a weak temperature dependence. Using this
expression for B2 in Eq. 4, we find that trans/kT0 vs. T/T0 is in
fact linear over the temperature range studied (See Fig. 5).
Defining   T/T0, we express this linear temperature depen-
dence as
trans	
kT0

 V  S , [6]
where V  trans(T0)/kT0; S  [(trans/kT0)/]1; and  
(T  T0)/T0.
In Table 2 we list the values of S and V for each of the mutants
and for the native protein, as determined from the data shown
in Fig. 5. If we now use this linear dependence of trans/kT0 in
the Van’t Hoff law, and noting that (T0/T) 	 (1  ), we find
that in the low  region (  0.02), the solubility line has the
very simple form
	 0expV 	 S	
 , [7a]
where
0 
 exp	   transT0	kT0  . [7b]
From Eq. 7a and 7b, we see at once that the increase or decrease
of the solubility  with increasing temperature is determined
entirely by the sign of the quantity K  ([trans(T0)/kT0]  S).
The value of this quantity is listed in column 4 of Table 2 for the
native and mutant proteins. In each case, the magnitude of the
slope S makes the dominant contribution to K. For the native
protein, K is 23.8, corresponding to the observed ‘‘normal’’
increase in solubility with increasing temperature. On the other
hand, for the P23V mutant, K is negative because of the large
positive value of S for this protein. Thus, the strong increase of
trans/kT0 with increasing temperature is responsible for the
retrograde solubility line for the P23V mutant and the other
mutants as well.
The location of the solubility line in the (, T) plane is
determined by the prefactor 0 according to Eq. 7b. Indeed, the
Fig. 5. Temperature dependence oftrans
C (T)/kT0 vs. T/T0 for nativeHGDand
the three mutant proteins, P23T, P23S, and P23V, as deduced by using Eq. 4.
Table 2. Values of the parameters V and S, describing
respectively the T  T0 intercept and the slope of
 trans()/kT0 vs.   T/T0 for each protein
Protein S V K  V  S
HGD 19 4.8 23.8
P23T 28 7.2 20.8
P23S 26 5.6 20.4
P23V 20 4.8 15.2
Both V and S were determined by using a least-square fit. These values are
reported to two significant figures in view of the scatter in the experimental
data as shown in Fig. 5.
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dramatic decrease in the observed solubility at T0 as one
compares P23V with P23S and P23T is, in fact, the result of an
increase in V, from 4.8 to 7.2. Thus, the large change in solubility
and consequent opacification of the lens is due to a relatively
small change of approximately trans(1)  2.4kT0, which ap-
pears as the exponent in Eq. 7b.
Aeolotopic Model and P23V Mutation. The striking feature of our
experimental data is the finding that although the mutations
dramatically change the solubility of the protein, they have a
negligible effect on the properties of the solution phase, such as
the LLPS or the concentration dependence of the protein
diffusivity. In effect, the mutations change the chemical poten-
tials of the solid phase but not those of the liquid phase. This
represents an inexplicable paradox if the interprotein interac-
tions are treated using a simple isotropic model. Indeed, in such
a model a change in the attractive energy as a result of the
mutation must have a proportional effect on both the coexist-
ence curve and the solubility line. In reality, however, as we have
emphasized previously (37), the interprotein interactions are
highly anisotropic and localized. The analysis of our data indi-
cates that a mutation at site 23 dramatically affects the temper-
ature dependence of the interprotein interaction. Indeed, ac-
cording to the estimates above, we deduce that the energy change
upon mutation in this region has a strong temperature depen-
dence, amounting to several kT over a30°C temperature range.
This energy magnitude is small compared with the typical energy
associated with crystal contacts. Interestingly, the x-ray structure
of native HGD crystals (39) indicates that site 23 is not directly
involved as a crystal contact. Furthermore, no crystal structure
is available for the site 23 mutants. Because the solubility at T0
is nearly the same for mutant and native proteins, it is reasonable
to assume that there is no significant structural change as a result
of the mutation.
Our data show that a local energy change of this magnitude
produces a negligible effect on the average pairwise interaction
(second virial coefficient and diffusivity) and on the liquid–
liquid coexistence in the solution phase. This observation finds
its natural explanation in the framework of the aeolotopic model
(37). In this model, we have shown that the thermodynamic
properties of the liquid phase can be described by a spatial
thermodynamic average of the highly anisotropic actual poten-
tial. Using the expression for the effective attractive energy given
in ref. 37, suitably generalized for attractive spots with different
energies and areas, it is possible to show that for a protein with
30 attractive spots, the aforementioned change of 2.4 kT0 in
the energy of one spot will translate into a 0.3% change in the
thermodynamically averaged effective energy in the solution
phase. This corresponds to 1°C shift in the coexistence curve,
which is within the level of uncertainty in the measurements of
LLPS. Thus, the apparent discrepancy between the interaction
energies in the solution phase vs. the solid phase is explicable in
terms of highly anisotropic interprotein interactions, which are
averaged out in the solution phase but are fully engaged in the
solid phase.
Role of Proline 23 in HGD. The overall structure of HGD has been
determined (39), and Raman, IR, and far-UV CD analyses
suggest that mutations at site 23 produce no major structural
changes. Therefore, the observed dramatic changes in solubility,
and especially the retrograde temperature dependence in the
mutant proteins, must be ascribed to local changes in the im-
mediate vicinity of site 23. The fact that, regardless of the residue
replacing proline, the solubility curve always changes to retro-
grade, suggests the importance of the removal of the proline.
Indeed, it has been found that the addition of proline at site 24,
while the Val or Thr residues are left at position 23, restores the
normal temperature dependence of the solubility of the protein
(1). Thus we can conclude that the presence of proline in the
vicinity of site 23 contributes importantly to the binding energy,
decreasing it as the temperature increases. This conclusion
presents an interesting challenge to theoretical analysis using
molecular dynamic simulations.
Conclusions
We have reported the location of the boundary for LLPS and the
solubility line, as well as the concentration and temperature
dependence of the diffusion coefficient, in solutions of the P23V
mutant of HGD. We have compared these properties with those
of the native HGD and have found conditions under which
crystals of the mutant P23V can be formed. As is the case with
two other mutants at this position, P23V shows a retrograde
solubility line, i.e., the solubility decreases with increasing tem-
perature, in dramatic contrast to that of the native protein. As
a result, at body temperature the solubility of the mutant is much
less than that of the native protein. On the other hand, solution
properties such as the liquid–liquid phase boundary and the
collective diffusion coefficient are essentially unchanged by this
mutation. The apparent inconsistency between the effect of
mutation in the solution and solid phases can be understood in
the framework of the aeolotopic model of highly anisotropic
interactions between proteins. Analysis of the solubility line
shows that the mutation causes changes in the binding energy in
a strongly temperature-dependent fashion. As the temperature
changes from 5° to 35°C, the binding energy of the mutant
increases by 2.4 kT. Comparison with data on other mutants
(1) suggests that the underlying source of these binding energy
changes is associated with the presence or absence of proline in
the vicinity of position 23.
Materials and Methods
Cloning, Expression, and Isolation of Proteins. Recombinant HGD
was prepared by amplification of the coding sequence from a
human fetal lens cDNA library, as described previously (1).
Mutagenesis was performed with the QuikChange site-directed
mutagenesis kit from Stratagene (La Jolla, CA), with primers
synthesized by MWG Biotech (High Point, NC) also described
elsewhere (1). The plasmidDNAobtained after mutagenesis was
sequenced with the T7 promoter primer and found to contain the
desired mutation and no other sequence changes. Overexpres-
sion of the recombinant proteins (HGD, P23V), and their
isolation and purification, were carried out as described previ-
ously (1). In all cases, the crystallins were obtained from the
soluble fraction. Each batch of protein prepared was analyzed by
using electrospray ionization mass spectrometry (Biopolymers
Laboratory, Center for Cancer Research, Massachusetts Insti-
tute of Technology). The average masses for proteins deter-
mined in this study were based on three batches of each protein
and were HGD: 20,610  1 and P23V: 20,612  1 (consistent
with ref. 1). For HGD and the mutant proteins used in this study,
an extinction coefficient of 41.4 mM1cm1 at 280 nm was used
(40). The volume fraction of the protein is expressed as  csp,
where c is the concentration in milligrams per milliliter and sp
is the partial specific volume, 7.1  104 ml/mg (18).
QLS.QLSwas performed with an instrument built in-house, using
a coherent 35-mW, 632.8-nm He-Ne laser (Coherent Radiation,
Santa Clara, CA) and a PD2000DLSPLUS 256-channel correlator
(Precision Detectors, Bellingham, MA). The scattering angle in
all experiments was 90°. The temperature was controlled by using
an external circulating water bath, with the sample temperature
monitored by a thermocouple probe positioned beside the
sample vial during measurements. The measured correlation
functions were analyzed by the Precision Deconvolve 4.4 soft-
ware method (Precision Detectors), which determines the total
scattered light intensity vs. the diffusion coefficient of the
16860  www.pnas.orgcgidoi10.1073pnas.0707412104 McManus et al.
sample. Protein solutions were prepared at the desired concen-
tration in 0.1 M sodium phosphate buffer (20 mM DTT/0.02%
sodium azide) and then filtered through 0.02-m Anatop filters
(Whatman, Clifton, NJ) before measurement. Cylindrical glass
tubes (Kimble, Vineland, NJ) with an internal diameter of 0.4 cm
were used for QLS measurements.
Measurement of LLPS. P23V solutions, filtered through 0.22-m
PDVF filters (Millipore, Billerica, MA) of known concentration
in 0.4-cm-diameter glass tubes, were placed in a cell with
transparent windows, connected to an external circulating water
bath. The samples were cooled to just below the solubility line
(4°C) and allowed to equilibrate. There is a very narrow region,
below the solubility line and above the coexistence curve, where
the protein exists as a homogeneous monomeric solution. It is
important to ensure that the protein is in monomeric form
before the temperature is lowered to measure LLPS, so partic-
ular care was taken in this regard. The temperature inside the
cell was measured by a thermocouple probe placed in an
identical glass vial containing water, inside the same cooled cell.
A 4-mW He-Ne laser was focused on the sample, and the
transmitted light intensity was detected by a photomultiplier
connected to a voltmeter. The initial light intensity value was
recorded. The cell was then cooled, and the transmitted light
intensity was monitored. When the light intensity fell to half of
its initial value, the temperature at which this occurred was
recorded. When the transmitted intensity dropped further,
below 1%, the cell was heated and the temperature at which the
transmitted intensity reached half the initial value again was
recorded. The phase separation temperature, Tph, was taken as
the average of the clouding and clearing temperatures. Interac-
tions between -crystallins are attractive and are also charac-
terized by a high content of free cysteine residues, which leaves
these proteins susceptible to disulfide-bond formation. Here we
have avoided the formation of these covalently linked aggregates
with the addition of DTT (41).
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